ONCOLOGY . RADIUM-223 AND CONCOMITANT THERAPIES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: AN INTERNATIONAL, EARLY ACCESS, OPEN-LABEL, SINGLE-ARM PHASE 3B TRIAL (SAAD, F. / CARLES, J. / GILLESSEN, S.)